Date: 2015-05-21
Type of information: Establishment of a new subsidiary in the EU
Compound:
Company: Osiris Therapeutics (USA - MD)
Therapeutic area: Regenerative Medicine
Type agreement: establishment of a new subsidiary
Action mechanism:
Disease:
Details: * On May 21 2015, Osiris Therapeutics announced that it is evaluating the establishment of an international, ex-U.S. subsidiary in recognition of its expanding research and commercial business operations. The Company is currently evaluating different locations, including United Kingdom , Singapore and Switzerland .
Financial terms:
Latest news:
